NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Cambridge University Hospitals NHS Foundation Trust, U.K. is adopting the Masimo W1™ advanced health tracking watch ...
Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports. Actionable insights into research performance. Detailed analysis of strengths and ...
Cambridge University Hospitals NHS Foundation Trust, which runs Addenbrooke’s, is removing all its funding for the hospice – ...
AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London - ...
Hosted on MSN
New £2.3bn hospital 'ambitious but necessary'
Plans for a new £2.3bn acute hospital for part of Cambridgeshire seeing rapid population growth have been described as ambitious but necessary. Cambridge University Hospitals NHS Foundation Trust (CUH ...
- AVB-101 is an investigational one-time therapy designed to deliver a functional copy of the GRN gene directly to the brain, thereby potentially restoring progranulin levels and stopping disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback